Reunion Neuroscience
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Reunion Neuroscience sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Reunion Neuroscience: 5 sponsored US clinical trials, 2 recruiting.
Reunion Neuroscience sponsors 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Adjustment Disorder, with 1 trials.
Upper-quartile sponsor footprint
Reunion Neuroscience sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
NCT07489651
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
NCT07002034
RE104 Radiolabeled Mass Balance (hAME) Study
NCT07146191
RE104 Clinical Lactation Study
NCT06659263
RE104 Safety and Efficacy Study in Postpartum Depression
NCT06342310
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
Therapeutic Areas
What is open in the Reunion Neuroscience pipeline
2 recruiting of 5 indexed (40% open); 3 completed (60%).
Phase mix: 0 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Adjustment Disorder (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Reunion Neuroscience: open-pipeline peers nationwide
Peers matched on 5 registered trials and 40% open enrollment, not the therapeutic-area sidebar.
Reunion Neuroscience sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 40% open enrollment (± trial volume)
- Ad scientiam · 40% recruiting · 5 trials
- Alto Neuroscience · 40% recruiting · 10 trials
- Bonafide Health · 40% recruiting · 5 trials
- Brooks Rehabilitation · 40% recruiting · 5 trials
Related
What to do with this Reunion Neuroscience page
5 registered trials is a research-attention snapshot, not an endorsement of Reunion Neuroscience or any single study.
- 2 of Reunion Neuroscience's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Adjustment Disorder is the condition Reunion Neuroscience studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Adjustment Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Reunion Neuroscience pipeline card: 5 registered trials from official public datasets.Report a data error.